Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Olorinab; Drug: Placebo Sponsor: Arena Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials